ARS Pharmaceuticals, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

SPRY

organization

SIC: 2834

SEC Insider

$235.8M

598 transactions

Summary

ARS Pharmaceuticals, Inc. (SPRY) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $109.8MSales: $121.4M45 insiders

Date	Insider	Type	Value
2026-06-12	Karas Eric(Chief Commercial Officer)	Sell	$250K
2026-06-12	Karas Eric(Chief Commercial Officer)	M	$38K
2026-06-12	Fitzpatrick Alexander A(Chief Legal Officer)	Sell	$34K
2026-06-24	Dadoo Rajeev	A	$0
2026-06-24	SCHNEIDER PHILLIP M	A	$0
2026-06-24	Joint reporting: RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; Kolchinsky Peter; Shah Rajeev M.; RA Capital Nexus Fund II, L.P.	A	$0
2026-06-24	SAUNDERS BRENT L	A	$0
2026-06-24	Thompson Peter A.	A	$0
2026-06-24	Shawver Laura	A	$0
2026-06-24	Islam Saqib	A	$0
2026-06-24	Shah Pratik	A	$0
2026-06-24	Kelly Michael	A	$0
2026-06-12	Karas Eric(Chief Commercial Officer)	M	$0
2026-01-02	Lowenthal Richard E(PRESIDENT AND CEO)	A	$0
2026-01-02	Lowenthal Richard E(PRESIDENT AND CEO)	A	$0
2026-01-02	Dorsey Brian(Chief Operating Officer)	A	$0
2026-01-02	Fitzpatrick Alexander A(Chief Legal Officer)	A	$0
2026-01-02	Scott Kathleen D.(Chief Financial Officer)	A	$0
2026-01-02	Chakma Justin(Chief Business Officer)	A	$0
2026-01-02	Karas Eric(Chief Commercial Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ARS Pharmaceuticals, Inc. — Contributions, Lobbying & Contracts | Poliscope